GSA Capital Partners’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,040
Closed -$314K 2070
2025
Q4
$314K Sell
3,040
-4,843
-61% -$471K 0.03% 1144
2025
Q3
$712K Buy
7,883
+5,373
+214% +$471K 0.06% 612
2025
Q2
$221K Sell
2,510
-341
-12% -$29.6K 0.02% 1458
2025
Q1
$260K Sell
2,851
-231
-7% -$20.8K 0.02% 1248
2024
Q4
$266K Buy
+3,082
New +$279K 0.02% 1267
2024
Q3
Sell
-13,316
Closed -$1.22M 1925
2024
Q2
$1.22M Sell
13,316
-5,293
-28% -$473K 0.09% 378
2024
Q1
$1.69M Buy
18,609
+8,744
+89% +$766K 0.13% 173
2023
Q4
$803K Sell
9,865
-3,345
-25% -$262K 0.07% 508
2023
Q3
$1.05M Buy
13,210
+1,480
+13% +$119K 0.09% 365
2023
Q2
$924K Buy
11,730
+2,886
+33% +$226K 0.09% 358
2023
Q1
$687K Buy
+8,844
New +$682K 0.07% 518

Other funds holding PPH